Hypertension: Strengths and limitations of the JNC 8 hypertension guidelines

Nature Reviews Cardiology

Volumn 11, Issue 4, 2014, Pages 189-190

  Mancia, Giuseppe ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL MEDICINE; DIABETES MELLITUS; EVIDENCE BASED PRACTICE; HUMAN; HYPERTENSION; MEDICATION COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHORT SURVEY;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; HUMANS; HYPERTENSION; PRACTICE GUIDELINES AS TOPIC;

EID: 84897082828     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2014.12     Document Type: Short Survey

References (10)

1. James, P. A. et al. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA http://dx.doi.org/10.1001/jama. 2013.284427
2. Chobanian, A V. et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289, 2560-2572 (2003
3. Egan, B M., Zhao, Y. & Axon, R. N. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 303, 2043-2050 (2010
4. Mancia, G. et al. 2007 guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25, 1105-1187 (2007
5. American Diabetes Association. Hypertension management in adults with diabetes. Diabetes Care 27 (Suppl. 1), S65-S67 (2004
6. Zanchetti, A., Grassi, G. & Mancia, G. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered?. A critical reappraisal. J. Hypertens. 27, 923-934 (2009
7. Mancia, G. & Grassi, G. Aggressive blood pressure lowering is dangerous. The J curve: Pro side of the argument. Hypertension 63, 29-36 (2014
8. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288, 2981-2997 (2002
9. Mancia, G. & Grassi, G. Individualization of antihypertensive drug treatment. Diabetes Care 36 (Suppl. 2), S301-S306 (2013
10. Mancia, G. et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 31, 1281-1357 (2013